ENTRY       D00710                      Drug
NAME        Valproate sodium (USAN);
            Sodium valproate (JP18);
            Depakene (TN);
            Selenica (TN)
PRODUCT
  GENERIC   VALPROATE SODIUM (Athenex Pharmaceutical Division)
            VALPROATE SODIUM (Fresenius Kabi USA)
            VALPROATE SODIUM (Fresenius Kabi USA)
            VALPROATE SODIUM (Hikma Pharmaceuticals USA)
            VALPROATE SODIUM (Hikma Pharmaceuticals USA)
FORMULA     C8H15O2. Na
EXACT_MASS  166.097
MOL_WEIGHT  166.1933
CLASS       Cardiovascular agent
             DG01575  Calcium channel blocker
              DG01573  Calcium channel T type blocker
            Neuropsychiatric agent
             DG03199  Antiepileptic agent
              DG02035  Fatty acid antiepileptic
REMARK      Therapeutic category: 1139 1179
            ATC code: N03AG01
            Chemical structure group: DG00849
            Product (DG00849): D00399<US> D00304<US> D00710<JP/US>
EFFICACY    Anticonvulsant, Antimanic, Antimigraine, Antiepileptic
COMMENT     Fatty acid derivative
TARGET      ABAT [HSA:18] [KO:K13524]
            SSADH [HSA:7915] [KO:K00139]
            GAD [HSA:2571 2572] [KO:K01580]
            CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]
  PATHWAY   hsa04020(8911+8912+8913)  Calcium signaling pathway
            hsa04727(18+2571+2572)  GABAergic synapse
INTERACTION  
STR_MAP     map07033  Anticonvulsants
            map07036  Calcium channel blocking drugs
            map07048  Antimigraines
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AG Fatty acid derivatives
                 N03AG01 Valproic acid
                  D00710  Valproate sodium (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Anticonvulsants, Other
               Valproic Acid
                D00710  Valproate sodium (USAN)
             Antimigraine Agents
              Antimigraine Agents, Other
               Valproic Acid
                D00710  Valproate sodium (USAN)
             Bipolar Agents
              Mood Stabilizers
               Valproic Acid
                D00710  Valproate sodium (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               113  Antiepileptics
                1139  Others
                 D00710  Valproate sodium (USAN); Sodium valproate (JP18)
               117  Psychotropics
                1179  Others
                 D00710  Valproate sodium (USAN); Sodium valproate (JP18)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01573  Calcium channel T type blocker
                DG00849  Valproic acid
                 D00710  Valproate sodium
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02035  Fatty acid antiepileptic
                DG00849  Valproic acid
                 D00710  Valproate sodium
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D00710  Valproate sodium
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Calcium channels
                CACNA1-T
                 D00710  Valproate sodium (USAN) &lt;JP/US&gt;
             Enzymes
              Oxidoreductases (EC1)
               Dehydrogenases
                SSADH
                 D00710  Valproate sodium (USAN) &lt;JP/US&gt;
              Transferases (EC2)
               Aminotransferase
                ABAT
                 D00710  Valproate sodium (USAN) &lt;JP/US&gt;
              Lyases (EC4)
               Carboxy-lyases
                GAD
                 D00710  Valproate sodium (USAN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00710  Sodium valproate
              D00710  Sodium valproate tablets
              D00710  Sodium valproate extended-release tablets A
              D00710  Sodium valproate extended-release tablets B
              D00710  Sodium valproate syrup
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00710
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01573  Calcium channel T type blocker
                DG00849  Valproic acid
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02035  Fatty acid antiepileptic
                DG00849  Valproic acid
DBLINKS     CAS: 1069-66-5
            PubChem: 7847775
            ChEBI: 9925
            LigandBox: D00710
            NIKKAJI: J7.236B
ATOM        11
            1   C1c C    24.8619  -18.6957
            2   C1b C    24.8619  -17.3175
            3   C1b C    23.6530  -19.4139
            4   C6a C    26.0650  -19.4139
            5   C1b C    23.6472  -16.6109
            6   C1b C    22.4441  -18.6957
            7   O6a O    27.2738  -18.6957
            8   O6a O    26.0650  -20.8098 #-
            9   C1a C    22.4384  -17.3175
            10  C1a C    21.2412  -19.4139
            11  Z   Na   28.5001  -20.7280 #+
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     4   7 2
            7     4   8 1
            8     5   9 1
            9     6  10 1
///
